30
Mainstream framing
provisional
Why this rating?
· 1 signal
▾
Signals flagged in the original
- ›headline asserts a conclusion / scare-quotes
Moderna and Merck report trial results on mRNA therapy for melanoma
Moderna and Merck have reported findings from a clinical trial that suggest their mRNA therapy can significantly lower the chances of melanoma recurrence. The treatment works by enhancing the immune system's ability to attack melanoma cells.
Our neutral summary
Moderna and Merck have reported findings from a clinical trial that suggest their mRNA therapy can significantly lower the chances of melanoma recurrence. The treatment works by enhancing the immune system's ability to attack melanoma cells.
Read the full story at Scientific American ↗
The reporting belongs to
Scientific American;
we don't reproduce it.
You can compare how outlets framed this story below.